PONIARD PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.1 - SECTION 906 CEO CERTIFICATION - May 12, 2011

Attached files

file filename
10-Q - FORM 10-Q - PONIARD PHARMACEUTICALS, INC.d10q.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex311.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex322.htm

Exhibit 32.1

CERTIFICATION OF QUARTERLY REPORT

I, Ronald A. Martell, Chief Executive Officer of Poniard Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350, that:

 

  a. the Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

  b. the information contained in the Report 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 13, 2011     By:   /s/    RONALD A. MARTELL        
      Ronald A. Martell
      Chief Executive Officer

PONIARD PHARMACEUTICALS, INC. Reports